Canada's LAB International acquires Danish testing laboratory  

2005.02.18
Scantox, a Danish preclinical testing laboratory based near Copenhagen, has been acquired by the Canadian pharmaceutical company LAB International for DKK 28 mn

Scantox, a Danish preclinical testing laboratory based near Copenhagen, has been acquired by the Canadian pharmaceutical company LAB International for DKK 28 mn (USD 4.8 mn). Dr. Halvor Jaeger, CEO of Lab International says the acquisition will help the company to double its current revenues in 2005, and to expand its product offering to existing clients.

 

LAB International, comprising LAB Pharma and LAB research, is an integrated drug development company. Following the acquisition, LAB Research will be operating contract facilities in Denmark, Hungary, the US and Canada with a total of 375 staff.

 

Scantox was founded in 1977, and employs 135 people at its premises in Ejby south-west of Copenhagen. The firm performs studies on a contract basis for companies in the pharmaceutical, medical device, food, agrochemical and industrial chemical industries. In 2004, Scantox generated operating profits before depreciations of DKK 20 mn (USD 3.4 mn). The news is reported by financial daily newspaper Børsen and on Scantox' website.

 

Link > Scantox 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×